WallStSmart
UPC

Universe Pharmaceuticals Inc

NASDAQ: UPC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$3.21
-0.60% today

Updated 2026-05-01

Market cap
$1.74M
P/E ratio
P/S ratio
0.10x
EPS (TTM)
$-8.06
Dividend yield
52W range
$2 – $11
Volume
0.0M

Universe Pharmaceuticals Inc (UPC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$28.51M$33.23M$30.70M$47.98M$40.14M$32.31M$23.02M$17.86M
Revenue growth (YoY)+16.5%-7.6%+56.3%-16.3%-19.5%-28.7%-22.4%
Cost of revenue$15.11M$19.82M$16.61M$22.66M$18.25M$21.99M$16.95M$11.56M
Gross profit$13.41M$13.41M$14.09M$25.33M$21.89M$10.32M$6.07M$6.30M
Gross margin47.0%40.3%45.9%52.8%54.5%31.9%26.4%35.3%
R&D$789382.00$618437.00$583125.00$5.47M$7.62M$4.86M$3.60M$671761.00
SG&A$704866.00$713647.00$1.24M$3.30M$2.53M$2.22M$9.88M$4.21M
Operating income$9.66M$9.75M$10.25M$13.59M$-7.02M$-3.53M$-8.02M$-2.92M
Operating margin33.9%29.4%33.4%28.3%-17.5%-10.9%-34.8%-16.3%
EBITDA$10.11M$10.17M$10.61M$14.20M$-6.40M$-3.18M$-2.92M
EBITDA margin35.5%30.6%34.6%29.6%-15.9%-9.9%0.0%-16.4%
EBIT$9.66M$9.76M$10.20M$13.75M$-6.93M$-3.69M$-8.02M$-3.44M
Interest expense$164922.00$129268.00$123760.00$101604.00$162400.00$156788.00$278172.00$232041.00
Income tax$1.92M$2.10M$2.54M$2.36M$752419.00$2.25M$606704.00
Effective tax rate20.1%21.8%25.2%17.2%-9.4%-57.6%0.0%-19.8%
Net income$7.60M$7.55M$7.56M$11.32M$-8.74M$-6.16M$-8.73M$-3.67M
Net income growth (YoY)-0.7%+0.1%+49.8%-177.2%+29.5%-41.6%+57.9%
Profit margin26.7%22.7%24.6%23.6%-21.8%-19.1%-37.9%-20.6%